瑞香素体外联合抗生素抗MRSA的研究OACSTPCD
In vitro study of Daphne essential oil combined with antibiotics against MRSA
目的 了解瑞香素单独或联合抗生素体外抗耐甲氧西林金黄色葡萄球菌(MRSA)能力,为中药或联合抗生素治疗该菌的感染提供依据.方法 收集MRSA标准株及5株临床MRSA;检测瑞香素抗MRSA标准株及临床菌株菌株的MIC值,棋盘法观察瑞香素分别联合苯唑西林、红霉素、庆大霉素、克林霉素和左氧氟沙星联合对MRSA的作用MIC值.结果 瑞香素对所有MRSA菌株的MIC值为128 μg/mL,参照CLSI2022,所有菌株对青霉素、庆大霉素、克林霉素、苯唑西林和红霉素耐药,左氧氟沙星仅对USA300敏感,无万古霉素和利奈唑胺耐药株.瑞香素与左氧氟沙星有协同作用,与庆大霉素、克林霉素有相加作用,与苯唑西林、红霉素为拮抗作用.结论 瑞香素具有抗MRSA能力,对左氧氟沙星、庆大霉素和克林霉素具有协同或相加作用,联合抗菌中能降低这些抗生素的MIC值,从而降低细菌耐药性的产生.
Objective To investigate the ability of Daphne essential oil alone or in combination with antibiotics to combat methicillin-resistant Staphylococcus aureus(MRSA)in vitro,providing a basis for the use of traditional Chinese medicine or combined antibiotic therapy to treat infections caused by this bacterium.Methods MRSA standard strains and five clinical MRSA strains were collected.The minimum inhibitory concentration(MIC)of Daphne essential oil a-gainst standard and clinical MRSA strains was determined.The checkerboard method was used to observe the MIC values of Daphne essential oil combined with oxacillin,erythromycin,gentamicin,clindamycin,and levofloxacin against MRSA.Results The MIC value of Daphne essential oil against all MRSA strains was 128 μg/mL.According to CLSI 2022,all strains were resistant to penicillin,oxacillin,erythromycin,gentamicin,clindamycin,and levofloxacin,but not resistant to vancomycin and linezolid.Daphne essential oil showed a synergistic effect with levofloxacin,an additive effect with gen-tamicin and clindamycin,and an antagonistic effect with oxacillin and erythromycin.Conclusion Daphne essential oil has anti-MRSA capabilities and exhibits synergistic or additive effects with levofloxacin,gentamicin,and clindamycin.Combining these antibiotics with Daphne essential oil can reduce their MIC values,thereby reducing the development of bacterial resistance.
何霞飞;陈开森;邹立津
南昌大学第一附属医院烧伤科(江西南昌 330006)南昌大学第一附属医院检验科(江西南昌 330006)
中医学
耐甲氧西林金黄色葡萄球菌瑞香素体外实验
methicillin-resistant Staphylococcus aureusDaphnetinin vitro test
《广东医学》 2024 (009)
1113-1117 / 5
江西省中医药管理局科技计划课题(2021A130)
评论